EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents

Swathi Rejinthala iD, Srinivas Endoori iD, Vishnu Thumma iD, T Mondal iD

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202301456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Swathi Rejinthala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering Chemistry, Koneru Lakshmaiah Education Foundation, Aziznagar, Hyderabad, 500075, Telangana, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Dihydropyridines. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Core Research Grant of Science and Engineering Research Board, Department of Science and Technology, management of Curia India private limited.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we designed, synthesized and characterized a novel series of piperidine‐dihydropyridine hybrid compounds and characterized them by 1 H‐NMR, 13 C NMR, mass spectrometry (MS), and elemental analysis. Subsequently, we assessed their in vitro anticancer potentials against the human breast adenocarcinoma cell line MCF‐7 and the lung cancer cell line A‐549. Several of these compounds demonstrated significant activity, with IC 50 values ranging from 15.94 μM to 48.04 μM for A‐549 and 24.68 μM to 59.12 μM for MCF‐7, when compared to the reference drug Cisplatin.Notably, a compound featuring a 3‐fluoro substitution in the carboxamide series exhibited robust inhibitory effects, with an IC 50 of 15.94±0.201 μM against A‐549 cells and an IC 50 of 22.12±0.213 μM against MCF‐7 cells, respectively. Additionally, a compound containing a cyclobutyl ring displayed potent activity, with an IC 50 of 16.56±0.125 μM against A‐549 and an IC 50 of 24.68±0.217 μM against MCF‐7 cells, respectively. Furthermore, molecular docking studies against the Epidermal Growth Factor Receptor (EGFR) (PDB ID: 2J6M) revealed favourable binding scores and interactions, suggesting their potential as promising candidates for further investigation in the context of anticancer drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDihydropyridinesHumansMolecular StructureStructure-Activity RelationshipMolecular Docking SimulationProtein Kinase InhibitorsDrug Screening Assays, AntitumorCell ProliferationCell Line, TumorDrug Design

Stichwörter der Autor:innen

CytotoxicityDihydropyridinePiperdinecarboxamidesmolecular dockingsulfoxamides

Substanzen

Protein Kinase InhibitorsAntineoplastic AgentsDihydropyridines

Autor:innen und Institutionen

  • Department of Engineering Chemistry, Koneru Lakshmaiah Education Foundation, Aziznagar, Hyderabad, 500075, Telangana, India.
  • Department of Engineering Chemistry, College of Engineering, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh, 522302.
  • Department of Sciences and Humanities, Matrusri Engineering College, Hyderabad, Telangana, India, 500059.

ORCID-Profile: Swathi Rejinthala, Srinivas Endoori, Vishnu Thumma, T Mondal

Förderung

  • Core Research Grant of Science and Engineering Research Board
  • Department of Science and Technology
  • management of Curia India private limited
  • Dipartimento di Scienze e Tecnologie, Università degli Studi del Sannio

Zitieren

APA

Rejinthala, S., Endoori, S., Thumma, V., & Mondal, T. (2024). Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301456

Vancouver

Rejinthala S, Endoori S, Thumma V, Mondal T. Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301456

BibTeX
@article{Rejinthala2024,
  author = {Rejinthala, Swathi and Endoori, Srinivas and Thumma, Vishnu and Mondal, T},
  title = {Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202301456}
}
Kostenlos starten →